Caprolactam → HCID 131727824, compound

HRID 1867191Notes

Reaction equation

[C:1]1(=[O:8])[NH:7][CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.[Li+:9].[C:10]([S:14]([N-:17][S:18]([C:21]([F:24])([F:23])[F:22])(=[O:20])=[O:19])(=[O:16])=[O:15])([F:13])([F:12])[F:11]>>[C:1]1(=[O:8])[NH:7][CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.[Li+:9].[C:21]([S:18]([N-:17][S:14]([C:10]([F:13])([F:12])[F:11])(=[O:16])=[O:15])(=[O:19])=[O:20])([F:23])([F:22])[F:24]

Participants

Reactant 2

HCID 7768Caprolactam2×

HCID 3816071Lithium bis((trifluoromethyl)sulfonyl)azanide2×

Product 1

HCID 131727824HCID 131727824, compoundYield 150.6%

Conditions

Temperature: 40 °C

Procedure

5.9 g of purified caprolactam and 5 g of LiTFSI were introduced into a round-bottom flask and stirred gradually at 40° C. under nitrogen atmosphere for 5 minutes and then at room temperature for 4 hours to provide 10.5 g of the eutectic mixture of caprolactam with LiTFSI.

Sources & evidence

ORD record: ord-52a642566dc54c7daa520b85954c5492
Source dataset: uspto-grants-2009_12
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US07630117B2

Reaction notes

Loading…